Clinical and biological relevance of genomic heterogeneity in chronic lymphocytic leukemia.

Abstract excerpt

BACKGROUND: Chronic lymphocytic leukemia (CLL) is typically regarded as an indolent B-cell malignancy. However, there is wide variability with regards to need for therapy, time to progressive disease, and treatment response. This clinical variability is due, in part, to biological heterogeneity between individual patients' leukemias. While much has been learned about this biological variation using genomic...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Gene Expression Profiling
• Share to Genetic Heterogeneity
• Share to Leukemia, Lymphocytic, Chronic, B-Cell